《大行報告》花旗降港鐵(00066.HK)目標價至23元 憧憬招標改善為時過早
花旗發表研究報告,指對港府全面撤辣感到驚喜,但仍然認為鑒於目前息口水平及買家缺乏信心,短期內香港住宅需求依然受到抑制,認為憧憬發展商對港鐵項目入標意欲將改善是為時過早。
該行又指,港鐵2023年基本溢利按年下跌40%至63.64億元,遜於市場預期的70.18億元,主要由於期內物業發展入賬利潤大減80%。受惠於跨境運輸及高鐵業務恢復,去年香港車務經營虧損按年收窄76.5%至11.11億元。
港鐵表示今年內將重新推出東涌東站第一期項目作招標,惟花旗估計,港鐵從該項目中所獲取的經濟效益可能大大低於預期,因此維持「沽售」評級,目標價從26.5元下調至23元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.